1. DOP29 Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy. (25th January 2019) Authors: Moens, A; van der Woude, C; Julsgaard, M; Sebastian, S; Arebi, N; Alzinaty, M; Humblet, E; Kok, K B; Sheridan, J; Gilletta De Saint-Joseph, C; Nancey, S; Rahier, J-F; Bossuyt, P; Cremer, A; Dewit, S; Eriksson, C; Hoentjen, F; Krause, T; Louis, E; Macken, E Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP032 Outcome of pregnancies in female IBD patients treated with vedolizumab. (16th January 2018) Authors: Moens, A; van Hoeve, K; Humblet, E; Rahier, J -F; Bossuyt, P; Dewit, S; Franchimont, D; Macken, E; Nijs, J; Posen, A; Van Hootegem, A; Van Moerkercke, W; Vermeire, S; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗